Bristol-Myers Squibb Company to Present Data on Rheumatoid Arthritis Assets at American College of Rheumatology 2013 Annual Meeting

Bristol-Myers Squibb Company (NYSE: BMY) announced today that 20 abstracts have been accepted for presentation at the 2013 annual meeting of the American College of Rheumatology (ACR) taking place from October 25-30 in San Diego, CA. The breadth of data underscores the Company’s continued commitment to develop medicines that address the unmet medical needs of patients suffering from rheumatic and other immune-mediated diseases.

Help employers find you! Check out all the jobs and post your resume.